Healthcare Services

Malaria Vaccines Market Revenue Anticipated To Reach $27.18 Billion By 2030 With 34.3% CAGR

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Malaria Vaccines Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The market for malaria vaccines has experienced rapid expansion recently. It is forecast to rise from $6.24 billion in 2025 to $8.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 33.9%. This historical growth can be attributed to the significant malaria burden in affected regions, sustained global campaigns for malaria eradication, financial contributions from international health organizations, the challenges posed by antimalarial drug resistance, and the early achievements of first-generation malaria vaccines.

The malaria vaccines market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $27.18 billion, exhibiting a compound annual growth rate (CAGR) of 34.3%. This projected growth is driven by factors such as enhanced government investment in preventing infectious diseases, the expanding spread of malaria-susceptible areas due to climate change, a rising need for vaccines offering durable immunity, progress in vaccine development and clinical studies, and broader immunization outreach in developing nations. Key trends for the forecast period encompass the development of advanced malaria vaccines, a heightened emphasis on childhood vaccination initiatives, more public-private collaborations for vaccine distribution, an increased focus on multi-antigen and combined vaccine solutions, and the reinforcement of large-scale vaccination efforts in areas where the disease is prevalent.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

What Market Drivers Are Helping Shape The Malaria Vaccines Market Expansion?

The increasing occurrence of mosquito-borne illnesses is anticipated to fuel the expansion of the malaria vaccine market in the future. These diseases encompass a wide range of sicknesses transmitted through the bite of an infected mosquito. Specifically, the RTS, S/AS01 (RTS, S) malaria vaccine serves to prevent and mitigate the effects of such infectious diseases by conditioning the immune system to identify and combat the parasite. For example, data from December 2024 by the UK Health Security Agency (UKHSA), a UK government department, revealed that the 2023 annual malaria report recorded 2,106 imported malaria cases in the UK. This figure represents a 26% increase compared to the cases reported in 2022. Consequently, the growing frequency of mosquito-related diseases is stimulating the expansion of the malaria vaccine market.

Which Segment Divisions Form The Structure Of The Malaria Vaccines Market?

The malaria vaccines market covered in this report is segmented –

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

What Trends Are Influencing The Malaria Vaccines Market Outlook?

Leading companies in the malaria vaccines market are concentrating on developing innovative solutions like next-generation recombinant vaccines to meet escalating demand driven by increasing malaria prevalence, government support, and expanding immunization programs. These advanced recombinant vaccines utilize sophisticated genetic engineering techniques to target multiple stages of the malaria parasite’s life cycle, offering improved immune responses and longer-lasting protection compared to traditional vaccines, which often target a single stage and provide limited efficacy. For instance, in October 2025, the Government of the Republic of Zambia launched the malaria vaccine R21/Matrix-M as part of its Expanded Programme on Immunisation. This vaccine, a collaborative effort by the University of Oxford and the Serum Institute of India, employs a recombinant protein platform combined with the Matrix-M adjuvant to enhance immune response. It is administered in a four-dose schedule starting from 6 months of age and is designed to complement existing anti-malaria measures. The vaccine demonstrates higher efficacy rates and aims to protect children in high and moderate transmission districts throughout Zambia, significantly contributing to malaria elimination efforts.

Which Companies Form The Competitive Landscape Of The Malaria Vaccines Market?

Major companies operating in the malaria vaccines market are GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc

Access The Complete Malaria Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Which Region Is The Primary Market For The Malaria Vaccines Market?

North America was the largest region in the malaria vaccines market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Malaria Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=13698&type=smp

Browse Through More Reports Similar to the Global Malaria Vaccines Market 2026, By The Business Research Company

Generalized Anxiety Disorder Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Antidepressant Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Panic Disorders Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795